Emergent BioSolutions Inc. (EBS)
Market Closed
17 Jul, 20:00
$
7. 63
-0.06
-0.7802%
$
415.35M Market Cap
- P/E Ratio
7.42% Div Yield
604,300 Volume
-4.4 Eps
$ 7.69
Previous Close 
Want to track EBS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Emergent BioSolutions Inc. (EBS) Statistics
Valuation metrics
Market Cap 415.35M
Enterprise value 806.98M
Trailing P/E (ttm) -44.88
Forward P/E 2.68
PEG ratio 0.37
Price/Sales (ttm) 0.58
Price/Book (mrq) 0.76
Enterprise Value/Revenue 1.19
Enterprise Value/EBITDA 5.22
Overview
Shares outstanding 52.1M
Float 47.11M
Shares short 9.65M
% Held by insiders 0.02%
% Held by institutions 0.82%
Average volume (10 days) 524.61K
Average volume (90 days) 733.6K
Price summary
52-Week low 5.62
52-Week high 14.06
Beta 2.36
50-Day moving average 8.2
200-Day moving average 9.57
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.01%
Operating margin 0.11%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.02%
Income Statement
Revenue (ttm) 742.9M
Revenue per share (ttm) 13.04
Quarterly revenue growth (yoy) -0.24%
Gross profit (ttm) 367.3M
EBITDA 262.3M
Net income to common (ttm) 52.6M
Diluted EPS (ttm) -0.17
Quarterly earnings growth (yoy) -0.24%
Balance Sheet
Total cash (mrq) 205.4M
Total cash per share (mrq) 3.09
Total debt (mrq) 583.7M
Total Debt/Equity (mrq) 1.1
Current ratio (mrq) 4.29%
Book value per share (mrq) 10.08
Cash Flow
Cash flow statement 170.6M
Levered free cash flow (LFCF) 205.39M
